About Hokkaido/Tohoku Region
Tohoku, a region of Japan’s Honshu Island, is known for its volcanoes, mountainous terrain and skiing. It's home to the tiny, pine-covered islets of Matsushima Bay, and Lake Towada, a huge crater lake renowned for its bright-blue color and surrounding forests. Tohoku's biggest city is Sendai, site of the Osaki Hachimangu Shinto shrine and ornate Zuihoden, the tomb of feudal lord Date Masamune. ― Google
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Chugai Pharmaceutical
7
Clinical Trials at Hokkaido/Tohoku Region
During the past decade, Hokkaido/Tohoku Region conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Correction Study of R744 in Renal Anemia Patients on Hemodialysis
2007-02-01
2008-10-01
Completed
50
Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study)
2007-01-01
2008-10-01
Completed
179
Phase II/III Clinical Study of R484iv (Ibandronic Acid) for Primary Osteoporosis
2007-03-01
2011-12-01
Completed
1,265
Clinical Study of R744 to Predialysis Patients( Phase III, Comparative Study in Comparison With Epoetin Beta)
2007-06-01
2008-11-01
Completed
187
Clinical Study of Epoetin Beta to Chemotherapy-Induced Anemia (CIA) Patients
2008-05-01
2009-09-01
Completed
160
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hokkaido/Tohoku Region
According to Clinical.Site data, the most researched conditions in "Hokkaido/Tohoku Region" are
"Hemodialysis Patients" (2 trials), "Anemia" (1 trials), "Anemia in Pre-Dialysis Patients" (1 trials), "Peritoneal Dialysis Patients" (1 trials) and "Predialysis Patients" (1 trials). Many other conditions were trialed in "Hokkaido/Tohoku Region" in a lesser frequency.
Clinical Trials Intervention Types at Hokkaido/Tohoku Region
Most popular intervention types in "Hokkaido/Tohoku Region" are "Drug" (7 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.
The name of intervention was led by "R744" (5 trials), "1.0mg ibandronic acid" (1 trials), "2.5mg RIS" (1 trials), "Calcium and Vitamine D3" (1 trials) and "Epoetin beta" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hokkaido/Tohoku Region
The vast majority of trials in "Hokkaido/Tohoku Region" are
7 trials for "All" genders.
Clinical Trials Status at Hokkaido/Tohoku Region
Currently, there are NaN active trials in "Hokkaido/Tohoku Region".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 7 completed trials in Hokkaido/Tohoku Region,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hokkaido/Tohoku Region, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 7 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".